What is the treatment for nummular headache?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Nummular Headache

For nummular headache, initiate treatment with gabapentin as first-line therapy, with NSAIDs and botulinum toxin type A as highly effective alternatives, particularly when gabapentin fails or is not tolerated. 1, 2

First-Line Treatment Options

  • Gabapentin demonstrates the highest response rate (67.7%) among oral medications and should be considered the primary pharmacologic intervention for nummular headache 1

  • NSAIDs show a 65.6% response rate and represent an excellent alternative first-line option, particularly for patients who prefer to avoid neuromodulating agents 1

  • Tricyclic antidepressants (such as amitriptyline) have a 44.4% response rate and can be considered when gabapentin or NSAIDs are ineffective or contraindicated 1

Second-Line Treatment: Botulinum Toxin Type A

  • Botulinum toxin type A (BoNT-A) achieves a 100% response rate in reported cases and should be strongly considered for patients with intractable nummular headache who fail oral medications 1, 2

  • The typical injection protocol involves 25 units of BoNT-A divided among 10 injection sites within and around the circumscribed painful area 2

  • Symptom reduction typically begins 6-10 days following injection, with effects lasting approximately 14 weeks, requiring repeat injections for sustained benefit 2

  • BoNT-A is particularly effective for patients experiencing allodynia, tenderness, and paresthesias in the affected area 2

Treatment Algorithm

  1. Initial approach: Start with gabapentin or NSAIDs based on patient preference and comorbidities 1

  2. If inadequate response after 4-6 weeks: Switch to the alternative first-line agent (gabapentin if NSAIDs were tried first, or vice versa) 1

  3. If both first-line agents fail: Consider tricyclic antidepressants 1

  4. For refractory cases: Proceed to botulinum toxin type A injections, which have demonstrated efficacy even when NSAIDs, gabapentin, and local anesthetics have failed 2

  5. For mild cases: Simple reassurance may be sufficient, as many patients experience minimal disability and treatment may not be necessary 3

Important Clinical Considerations

  • Early diagnosis is associated with better outcomes: Patients diagnosed within one year of symptom onset are more likely to achieve complete resolution compared to those with delayed diagnosis (median time to diagnosis is 18 months) 1

  • Female patients and younger age at onset predict better treatment response: These demographic factors are associated with higher rates of complete resolution 1

  • The pain typically affects a circumscribed round, oval, or elliptical area measuring 2-6 cm in diameter, most commonly in the parietal region 4, 3

  • Sensory disturbances including paresthesias, allodynia, and dysesthesias frequently accompany the pain and should be specifically addressed during treatment 4, 3

Critical Pitfalls to Avoid

  • Do not mistake nummular headache for secondary causes: Rule out local structural pathology before diagnosing primary nummular headache, as the focal nature can mimic secondary processes 3

  • Recognize that nummular headache can coexist with other primary headaches (such as migraine or tension-type headache) but follows an independent course requiring separate treatment 3

  • Avoid premature discontinuation of treatment: Many patients experience fluctuating symptoms with pseudoremissions where pain becomes very mild or presents only as discomfort, which should not be mistaken for treatment failure 3

  • The affected area remains fixed in location, shape, and size over time—any change in these characteristics should prompt reconsideration of the diagnosis 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.